Pharmx Technologies Limited (ASX:PHX)

Pharmx Technologies Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	55	86	56	23	22	20
Market Cap Growth	-29.80%	54.02%	144.74%	2.90%	8.94%	-60.92%
Enterprise Value	53	83	51	11	17	14
Last Close Price	0.08	0.13	0.09	0.04	0.03	0.03

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	-	-	-	-	-	80.52
Forward PE	-	21.25	21.25	21.25	21.25	21.25
PS Ratio	7.17	11.26	7.60	3.51	3.61	3.77
PB Ratio	2.35	3.68	3.50	1.42	1.00	0.87
P/TBV Ratio	4.74	7.44	13.45	7.48	2.50	8.19
P/FCF Ratio	67.85	106.50	-	7.13	2.04	6.37
P/OCF Ratio	66.21	103.92	-	7.10	2.02	6.18

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	6.90	10.93	7.02	1.63	2.78	2.65
EV/EBITDA Ratio	-	-	-	-	-	21.02
EV/EBIT Ratio	-	-	-	-	-	112.40
EV/FCF Ratio	65.33	103.40	-	3.32	1.57	4.48

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.02	0.02	0.06	0.02	0.00	0.01
Debt / EBITDA Ratio	-	-	27.09	-	-	0.32
Debt / FCF Ratio	0.67	0.67	-	0.08	0.00	0.10
Net Debt / Equity Ratio	-0.09	-0.09	-0.21	-0.81	-0.57	-0.23
Net Debt / EBITDA Ratio	1.16	1.16	37.25	11.97	58.33	-8.00
Net Debt / FCF Ratio	-2.52	-2.52	0.40	-4.04	-1.18	-1.71
Asset Turnover	0.33	0.33	0.30	0.20	0.18	0.17
Inventory Turnover	-	-	-	-	-	85.40
Quick Ratio	1.67	1.67	3.27	1.36	1.25	1.64
Current Ratio	2.33	2.33	3.33	1.37	1.84	1.68
Return on Equity (ROE)	-9.31%	-9.31%	-1.65%	0.50%	-3.89%	-0.57%
Return on Assets (ROA)	-4.78%	-4.78%	-0.26%	-2.57%	-1.23%	0.26%
Return on Invested Capital (ROIC)	-8.30%	-10.40%	4.25%	-10.30%	-4.89%	-0.79%
Return on Capital Employed (ROCE)	-7.30%	-7.30%	-0.60%	-7.60%	-2.70%	0.50%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	-3.34%	-2.13%	-0.47%	-7.78%	-4.75%	1.24%
FCF Yield	1.47%	0.94%	-14.66%	14.02%	49.13%	15.70%
Buyback Yield / Dilution	-3.58%	-3.58%	-0.06%	-0.17%	0.56%	-9.81%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error